The majority of adult HIV infections in sub-Saharan Africa occur in women, highlighting the importance of understanding HIV risk in this population. Numerous studies have suggested that perturbations of vaginal bacterial flora, including bacterial vaginosis (BV), may increase women's risk of HIV acquisition. Recently, molecular techniques for characterization of vaginal flora have enhanced our knowledge of the central role of uncultivated organisms in the microbial ecology of BV. Indeed, several novel bacterial species appear to be substantially more predictive of BV than bacteria previously identified through culture. Understanding the role of vaginal flora in mediating HIV risk is an important HIV prevention goal. The overarching aim of this proposal is to use cutting-edge molecular approaches to test the hypothesis that the presence of specific bacteria in the vaginal flora is associated with increased risk for HIV acquisition. To accomplish this objective, we will conduct a nested case-control study utilizing prospectively collected data from NIH-funded cohorts of women at risk for HIV in Mombasa and Kisumu, Kenya. Vaginal bacterial flora will be evaluated using two distinct and complementary molecular techniques: (1) quantitative 16S ribosomal DNA polymerase chain reaction (PCR) to identify and quantify species that are frequently associated with BV, and (2) broad range PCR with pyrosequencing (deep sequencing) to identify minority species and broad patterns of vaginal bacterial communities in women who acquire HIV versus those who remain HIV-seronegative. The proposed studies will be conducted by an experienced multidisciplinary team including basic scientists, clinicians, epidemiologists, and biostatisticians with an established record of collaborative HIV research in women.

Public Health Relevance

The findings from the proposed studies will be highly relevant to public health, holding great promise for the development of a vaginal health approach to HIV prevention based on eradication of high-risk vaginal bacteria. Successful completion of these studies could help to inform the development of urgently needed female-controlled, non-coitally linked HIV prevention strategies.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-TP-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Fred Hutchinson Cancer Research Center
United States
Zip Code
Lehman, Dara A; Ronen, Keshet; Blish, Catherine A et al. (2014) Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition. J Acquir Immune Defic Syndr 66:135-9
Drake, Alison L; Wagner, Anjuli; Richardson, Barbra et al. (2014) Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med 11:e1001608
Masese, Linnet; Baeten, Jared M; Richardson, Barbra A et al. (2014) Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis. J Infect Dis 209:1023-7
Graham, Susan M; Raboud, Janet; McClelland, R Scott et al. (2013) Loss to follow-up as a competing risk in an observational study of HIV-1 incidence. PLoS One 8:e59480
Masese, Linnet; Baeten, Jared M; Richardson, Barbra A et al. (2013) Incidence and correlates of Chlamydia trachomatis infection in a high-risk cohort of Kenyan women. Sex Transm Dis 40:221-5
Balkus, Jennifer E; Richardson, Barbra A; Mochache, Vernon et al. (2013) A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women. Sex Transm Dis 40:499-505
Odem-Davis, Katherine; Fleming, Thomas R (2013) Adjusting for unknown bias in non-inferiority clinical trials. Stat Biopharm Res 5:
Lagace-Wiens, Philippe R S; Duncan, Sarah; Kimani, Joshua et al. (2012) Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya. Sex Transm Dis 39:332-4